Pentoxifylline (Prokrea BCN SL)

N/A

Report date: 2025/05/23 20:00:56

Base Information

Drug NamePentoxifylline (Prokrea BCN SL)
Drug Alias NamePKB171PKB-171
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInfertility, Male
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProkrea BCN SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProkrea BCN SL
Active IndicationsN/A
Inactive IndicationsInfertility, Male

Other Information

ATC CodeN/A
Related LinksN/A